Clinical Trial Update: Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting on serum levels and pharmacokinetics of a new hepatitis B immune globulin in liver transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B immune globulin

Snippet

Sponsor: Instituto Grifols, S.A. | Conditions: Hepatitis B, Chronic | Phase 3 | Status: COMPLETED